Untargeted Metabolomics Identifies New Biomarkers for Latent Tuberculosis
New Frontiers in Diagnosing Latent Tuberculosis Infection Diagnosing latent tuberculosis infection (LTBI) has long been a clinical challenge, primarily because there is no single gold-standard test available to practitioners. Recent research published in BIO Integration suggests that the future of TB diagnostics may lie in the field of metabolomics—the study of chemical processes involving metabolites. … Read more